Healthcare software provider Health Catalyst (NASDAQ:HCAT) in Q2 CY2025, with sales up 6.3% year on year to $80.72 million. On the other hand, next quarter’s revenue guidance of $75 million was less ...

SALT LAKE CITY, Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, ...

SALT LAKE CITY, May 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. (HCAT) ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare ...

Across the recent three months, 4 analysts have shared their insights on Health Catalyst (NASDAQ:HCAT), expressing a variety of opinions spanning from bullish to bearish. The following table provides ...

Analysts' ratings for Health Catalyst HCAT over the last quarter vary from bullish to bearish, as provided by 6 analysts. The table below provides a concise overview of recent ratings by analysts, ...

Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY, Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a ...

Shares of healthcare data analytics company Health Catalyst (NASDAQ:HCAT) fell 8.4% in the afternoon session after fears of disruption from artificial intelligence spooked investors, leading to a ...

SALT LAKE CITY, March 11, 2025 /PRNewswire/ — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, ...

In the last three months, 8 analysts have published ratings on Health Catalyst (NASDAQ:HCAT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...